phenylalanyl-phenylalanyl-arginine chloromethyl ketone has been researched along with Urinary Bladder Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ezban, M; Freskgârd, PO; Kjalke, M; Persson, E; Rao, LV; Sorensen, BB; Williams, T | 1 |
1 other study(ies) available for phenylalanyl-phenylalanyl-arginine chloromethyl ketone and Urinary Bladder Neoplasms
Article | Year |
---|---|
Incorporation of an active site inhibitor in factor VIIa alters the affinity for tissue factor.
Topics: Amino Acid Chloromethyl Ketones; Binding Sites; Binding, Competitive; Cell Line; Cell Membrane; Circular Dichroism; Factor VIIa; Fibrin; Humans; Kinetics; Protein Conformation; Recombinant Proteins; Thromboplastin; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 1997 |